- Home
- OPBK vs DERM Comparison
OPBK vs DERM Comparison
Compare OPBK & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- DERM
- Stock Information
- Founded
- OPBK 2005
- DERM 2014
- Country
- OPBK United States
- DERM United States
- Employees
- OPBK N/A
- DERM N/A
- Industry
- OPBK Major Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- OPBK Finance
- DERM Health Care
- Exchange
- OPBK Nasdaq
- DERM Nasdaq
- Market Cap
- OPBK 192.9M
- DERM 165.6M
- IPO Year
- OPBK 2018
- DERM 2021
- Fundamental
- Price
- OPBK $13.71
- DERM $7.30
- Analyst Decision
- OPBK Hold
- DERM Strong Buy
- Analyst Count
- OPBK 1
- DERM 1
- Target Price
- OPBK $18.00
- DERM $9.00
- AVG Volume (30 Days)
- OPBK 164.0K
- DERM 197.3K
- Earning Date
- OPBK 07-24-2025
- DERM 08-11-2025
- Dividend Yield
- OPBK 3.55%
- DERM N/A
- EPS Growth
- OPBK 0.92
- DERM N/A
- EPS
- OPBK 1.42
- DERM N/A
- Revenue
- OPBK $81,356,000.00
- DERM $56,243,000.00
- Revenue This Year
- OPBK $20.23
- DERM $28.99
- Revenue Next Year
- OPBK $10.49
- DERM $52.61
- P/E Ratio
- OPBK $9.54
- DERM N/A
- Revenue Growth
- OPBK 4.15
- DERM N/A
- 52 Week Low
- OPBK $10.43
- DERM $3.54
- 52 Week High
- OPBK $18.57
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- OPBK 57.66
- DERM 55.87
- Support Level
- OPBK $13.06
- DERM $6.83
- Resistance Level
- OPBK $13.87
- DERM $8.00
- Average True Range (ATR)
- OPBK 0.42
- DERM 0.38
- MACD
- OPBK -0.01
- DERM 0.03
- Stochastic Oscillator
- OPBK 48.04
- DERM 52.49
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.